Calcium Oscillation Frequency Is a Potential Functional Complex Physiological Relevance Indicator for a Neuroblastoma-Based 3D Culture Model
Source abstract
Abstract
In vitro screening for drugs that affect neural function in vivo is still primitive. It primarily relies on single cellular responses from 2D monolayer cultures that have been shown to be exaggerations of the in vivo response. For the 3D model to be physiologically relevant, it should express characteristics that not only differentiate it from 2D but also closely emulate those seen in vivo. These complex physiologically relevant (CPR) outcomes can serve as a standard for determining how close a 3D culture is to its native tissue or which out of a given number of 3D platforms is better suited for a given application. In this study, Fluo-4-based calcium fluorescence imaging was performed followed by automated image data processing to quantify the calcium oscillation frequency of SHSY5Y cells cultured in 2D and 3D formats. It was found that the calcium oscillation frequency is upregulated in traditional 2D cultures while it was comparable to in vivo in spheroid and microporous polymer scaffold-based 3D models, suggesting calcium oscillation frequency as a potential functional CPR indicator for neural cultures.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: 3D Printing in Biomedical Research · Cellular Mechanics and Interactions · Neuroscience and Neural Engineering
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (62)
Show source-provided references
1. 10.1038/nbt0497-32810.1038/nbt0497-328 ↗
2. 10.1016/S0065-7743(08)60585-010.1016/S0065-7743(08)60585-0 ↗
3. 10.1146/annurev.pharmtox.40.1.19310.1146/annurev.pharmtox.40.1.193 ↗
4. 10.1126/science.287.5460.196010.1126/science.287.5460.1960 ↗
5. 10.1016/S1359-6446(05)03697-410.1016/S1359-6446(05)03697-4 ↗
6. 10.1046/j.1471-4159.2002.01237.x10.1046/j.1471-4159.2002.01237.x ↗
7. 10.1016/j.neulet.2006.07.01310.1016/j.neulet.2006.07.013 ↗
8. 10.1016/j.neulet.2005.10.03510.1016/j.neulet.2005.10.035 ↗
9. 10.1074/jbc.M20283220010.1074/jbc.M202832200 ↗
10. 10.1016/0956-5663(95)96931-N10.1016/0956-5663(95)96931-N ↗
11. 10.1016/S0956-5663(97)00012-210.1016/S0956-5663(97)00012-2 ↗
12. 10.1016/j.bios.2005.07.00510.1016/j.bios.2005.07.005 ↗
13. 10.1016/S0167-6296(02)00126-110.1016/S0167-6296(02)00126-1 ↗
14. 10.1016/j.drudis.2011.01.00910.1016/j.drudis.2011.01.009 ↗
15. 10.1177/108705710426504010.1177/1087057104265040 ↗
16. 10.1016/j.drudis.2012.12.00510.1016/j.drudis.2012.12.005 ↗
17. 10.1016/j.ceca.2011.02.00910.1016/j.ceca.2011.02.009 ↗
18. 10.1002/glia.2049410.1002/glia.20494 ↗
19. 10.1074/jbc.M10913920010.1074/jbc.M109139200 ↗
20. 10.1016/j.vascn.2003.10.00210.1016/j.vascn.2003.10.002 ↗
21. 10.1016/j.ygcen.2010.08.01010.1016/j.ygcen.2010.08.010 ↗
22. 10.1016/j.biomaterials.2008.03.01510.1016/j.biomaterials.2008.03.015 ↗
23. Haidekker, M. A. Advanced Biomedical Image Analysis; John Wiley & Sons, 2011; pp 441–496.10.1002/9780470872093 ↗
24. 10.1186/1471-2105-10-410.1186/1471-2105-10-4 ↗
25. Xie H.-r. · Chinese medical journal · 2010 · 123 · 1086
26. 10.1109/83.80663010.1109/83.806630 ↗
27. Li X. · 2005
28. 10.1016/j.biomaterials.2011.02.01910.1016/j.biomaterials.2011.02.019 ↗
29. 10.1089/ten.tea.2010.027310.1089/ten.tea.2010.0273 ↗
30. 10.1016/j.jneumeth.2008.06.03110.1016/j.jneumeth.2008.06.031 ↗
31. 10.1023/A:101459482550210.1023/A:1014594825502 ↗
32. 10.1016/j.bbrc.2006.10.02010.1016/j.bbrc.2006.10.020 ↗
33. 10.1016/S0304-3835(03)00101-010.1016/S0304-3835(03)00101-0 ↗
34. 10.1038/sj.onc.120909510.1038/sj.onc.1209095 ↗
35. 10.1038/sj.onc.120636210.1038/sj.onc.1206362 ↗
36. 10.1016/j.drudis.2015.10.00710.1016/j.drudis.2015.10.007 ↗
37. 10.1371/journal.pone.004507410.1371/journal.pone.0045074 ↗
38. 10.1016/j.brainres.2010.03.10210.1016/j.brainres.2010.03.102 ↗
39. 10.1016/j.neuro.2008.11.00110.1016/j.neuro.2008.11.001 ↗
40. 10.1007/978-3-211-73574-9_310.1007/978-3-211-73574-9_3 ↗
41. 10.1016/S0896-6273(03)00568-310.1016/S0896-6273(03)00568-3 ↗
42. 10.1016/j.neuro.2009.10.01510.1016/j.neuro.2009.10.015 ↗
43. 10.3233/JAD-2010-09136310.3233/JAD-2010-091363 ↗
44. 10.1016/0959-8049(95)00033-F10.1016/0959-8049(95)00033-F ↗
45. 10.1007/BF0303317810.1007/BF03033178 ↗
46. 10.1074/jbc.M111.25597610.1074/jbc.M111.255976 ↗
47. 10.1007/s00018-010-0447-y10.1007/s00018-010-0447-y ↗
48. 10.1016/j.cell.2010.12.03110.1016/j.cell.2010.12.031 ↗
49. Chin-Lee B. · FASEB J. · 2008 · 22 · 1151-112810.1096/fasebj.22.1_supplement.1151.28 ↗
50. 10.1523/JNEUROSCI.17-24-09520.199710.1523/JNEUROSCI.17-24-09520.1997 ↗
51. 10.1074/jbc.M00048720010.1074/jbc.M000487200 ↗
52. 10.1073/pnas.95.17.1025710.1073/pnas.95.17.10257 ↗
53. 10.1038/nmeth.383910.1038/nmeth.3839 ↗
54. 10.1016/j.bpj.2009.05.05410.1016/j.bpj.2009.05.054 ↗
55. 10.1182/blood-2010-11-32112510.1182/blood-2010-11-321125 ↗
56. 10.1371/journal.pone.004171710.1371/journal.pone.0041717 ↗
57. 10.1016/j.cub.2007.02.05810.1016/j.cub.2007.02.058 ↗
58. 10.1529/biophysj.106.08480610.1529/biophysj.106.084806 ↗
59. 10.1038/3507453210.1038/35074532 ↗
60. 10.1073/pnas.090021610610.1073/pnas.0900216106 ↗
61. 10.1016/j.febslet.2004.08.05510.1016/j.febslet.2004.08.055 ↗
62. 10.1091/mbc.e11-09-081110.1091/mbc.e11-09-0811 ↗